Credit Agricole S A Intercept Pharmaceuticals, Inc. Transaction History

Credit Agricole S A

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $77,922 - $145,938	7,800 New	7,800 $144,000
Q3 2022 Nov 10, 2022	SELL	$12.21 - $19.7 $210,012 - $338,840	-17,200 Reduced 68.8%	7,800 $109,000
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $38,970 - $61,410	-3,000 Reduced 10.71%	25,000 $371,000
Q2 2021 Aug 10, 2021	BUY	$15.46 - $24.5 $371,040 - $588,000	24,000 Added 600.0%	28,000 $559,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $45,425 - $88,712	2,350 Added 142.42%	4,000 $92,000

Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $11,016 - $19,111	450 Added 37.5%	1,650 $41,000
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $58,020 - $142,416	1,200 New	1,200 $76,000
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $975,120 - $2.11 Million	-17,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	17,000	17,000 $2.06 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.